MM-401 TFA is a peptide-derived inhibitor scaffold widely used to probe histone methyltransferase recognition and chromatin-associated interactions. Its sequence mimics key lysine-containing motifs within histone tails. Researchers investigate binding thermodynamics, structural rearrangements, and epigenetic complex formation. Applications span chromatin biochemistry, probe development, and structure-activity relationship analysis.
CAT No: R2692
CAS No:1442106-11-7
Synonyms/Alias:MM-401 TFA;1442106-11-7;MM-401 (TFA);CHEMBL4099772;HY-19554A;DA-65550;CS-0104334;F82461;N-[(3R,6S,9S,12R)-9-[3-(diaminomethylideneamino)propyl]-6-ethyl-12-methyl-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetrazacyclohexadec-12-yl]-2-methylpropanamide;2,2,2-trifluoroacetic acid;
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.